Dajian Capital

Dajian Capital structures its mandate across the early-stage continuum, participating in seed, growth, and pre-IPO rounds. This stage-agnostic approach within the early-to-late range lets the firm follow portfolio companies from formative capital raises through to their public-market listings. The inclusion of pre-IPO deployment suggests the firm maintains the local regulatory knowledge necessary for China's domestic listing venues, including the STAR Market and ChiNext.

As a domestically registered private equity manager, Dajian Capital deploys renminbi-denominated capital sourced from onshore limited partners. This structure avoids the Qualified Foreign Limited Partner (QFLP) channel that offshore USD funds must navigate, granting direct access to founding teams and deal opportunities in sectors where foreign ownership is restricted or scrutinized. In China's regulatory environment, an onshore registration can be a material structural asset.

Dajian's stage coverage places it across both categories. Seed and growth-stage investments align with venture capital activity, while pre-IPO rounds operate within the later-stage private equity domain. The firm does not appear to intervene in control buyouts or secondary transactions, which distinguishes it from traditional buyout-focused private equity managers.

No. Dajian Capital does not publish an AUM figure, and no third-party source has confirmed a specific number. This is consistent with the disclosure practices of many mid-market China-based private equity managers who raise capital from domestic institutional and high-net-worth investors without publicly reporting fund-level metrics.

While Dajian does not publish a formal regional focus, the firm's Shanghai headquarters positions it within the Yangtze River Delta ecosystem, which is home to a high density of technology, advanced manufacturing, and healthcare companies seeking growth capital. The broader domestic mandate likely extends to other technology clusters, with the Greater Bay Area representing a second major addressable market for early-stage and pre-IPO deal flow.